Moderate hypofractionation and stereotactic body radiation therapy in the treatment of prostate cancer

被引:4
|
作者
Beckta, Jason M. [1 ]
Nosrati, Jason D. [2 ]
Yu, James B. [1 ]
机构
[1] Yale Univ, Sch Med, Therapeut Radiol, New Haven, CT 06520 USA
[2] Michigan State Univ, Coll Human Med, E Lansing, MI 48824 USA
关键词
Prostate cancer; Radiation therapy; Hypofractionation; SBRT; SABR; CONVENTIONALLY FRACTIONATED RADIOTHERAPY; INTENSITY-MODULATED RADIOTHERAPY; QUALITY-OF-LIFE; EXTERNAL-BEAM RADIOTHERAPY; RANDOMIZED-TRIAL; NON-INFERIORITY; MULTIINSTITUTIONAL CONSORTIUM; 5-YEAR OUTCOMES; DOSE-ESCALATION; HIGH-RISK;
D O I
10.1016/j.urolonc.2019.01.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
For prostate cancer radiation therapy, daily sessions spanning approximately 2 months has been considered the standard of care for patients managed with curative intent. In recent years, data has emerged which supports the use of higher dose per fraction schemes leading to a reduced duration of treatment. This form of radiation-generally termed moderate hypofractionation or stereotactic body radiation therapy-increasingly appears to be a safe and effective alternative to the conventional course. This review summarizes salient data from the literature on outcomes, toxicities, and future directions for this innovative strategy of care. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:619 / 627
页数:9
相关论文
共 50 条
  • [1] Energy use in moderate hypofractionation and stereotactic body radiotherapy for prostate cancer
    Laughlin, Brady S.
    Anderson, Justin D.
    Hobbis, Dean
    Armstrong, Michael
    Vargas, Carlos E.
    Rong, Yi
    Yu, Nathan Y.
    [J]. BJU INTERNATIONAL, 2023, 132 (06) : 648 - 650
  • [2] Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer
    Ahmed, Kamran A.
    Barney, Brandon M.
    Davis, Brian J.
    Park, Sean S.
    Kwon, Eugene D.
    Olivier, Kenneth R.
    [J]. FRONTIERS IN ONCOLOGY, 2013, 2
  • [3] Stereotactic Body Radiation Therapy for Primary Treatment of Prostate Cancer
    Oliai, Caspian
    Lanciano, Rachelle
    Yang, Jun
    Lamond, John
    Arrigo, Steve
    Good, Michael
    Mooreville, Michael
    Garber, Bruce
    Brady, Luther
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (02): : 209 - 209
  • [4] Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancer
    Johnson, Skyler Bryce
    Soulos, Pamela R.
    Shafman, Timothy D.
    Mantz, Constantine A.
    Dosoretz, Arie P.
    Ross, Rudi
    Finkelstein, Steven E.
    Collins, Sean P.
    Suy, Simeng
    Brower, Jeffrey V.
    Ritter, Mark A.
    King, Christopher R.
    Kupelian, Patrick A.
    Horwitz, Eric M.
    Pollack, Alan
    Abramowitz, Matthew C.
    Hallman, Mark A.
    Faria, Sergio
    Gross, Cary P.
    Yu, James B.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 121 (02) : 294 - 298
  • [5] Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy Versus Moderate Hypofractionation for Clinically Localized Prostate Cancer
    Johnson, S. B.
    Soulos, P. R.
    Shafman, T. D.
    Mantz, C. A.
    Dosoretz, A.
    Ross, R.
    Finkelstein, S. E.
    Collins, S. P.
    Suy, S.
    Brower, J. V.
    Ritter, M. A.
    King, C. R.
    Kupelian, P. A.
    Horwitz, E. M.
    Pollack, A.
    Abramowitz, M. C.
    Hallman, M. A.
    Faria, S.
    Gross, C. P.
    Yu, J. B.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E242 - E242
  • [6] Advances in Treatment Techniques Stereotactic Body Radiation Therapy and the Spread of Hypofractionation
    Kavanagh, Brian D.
    Miften, Moyed
    Rabinovitch, Rachel A.
    [J]. CANCER JOURNAL, 2011, 17 (03): : 177 - 181
  • [7] Stereotactic body radiation therapy for prostate cancer
    Ishiyama, Hiromichi
    Teh, Bin S.
    Lo, Simon S.
    Mathews, Thomas
    Blanco, Angel
    Amato, Robert
    Ellis, Rodney J.
    Mayr, Nina A.
    Paulino, Arnold C.
    Xu, Bo
    Butler, Brian E.
    [J]. FUTURE ONCOLOGY, 2011, 7 (09) : 1077 - 1086
  • [8] Prostate cancer therapy with stereotactic body radiation therapy
    Pawlicki, Todd
    Cotrutz, Cristian
    King, Christopher
    [J]. IMRT, IGRT, SBRT: ADVANCES IN THE TREATMENT PLANNING AND DELIVERY OF RADIOTHERAPY, 2007, 40 : 395 - 406
  • [9] Stereotactic body radiation therapy for the primary treatment of localized prostate cancer
    Oliai, Caspian
    Lanciano, Rachelle
    Sprandio, Brian
    Yang, Jun
    Lamond, John
    Arrigo, Steven
    Good, Michael
    Mooreville, Michael
    Garber, Bruce
    Brady, Luther W.
    [J]. JOURNAL OF RADIATION ONCOLOGY, 2013, 2 (01) : 63 - 70
  • [10] Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer
    Muldermans, Jonathan L.
    Romak, Lindsay B.
    Kwon, Eugene D.
    Park, Sean S.
    Olivier, Kenneth R.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 95 (02): : 696 - 702